Paroxysmal Nonkinesigenic Dyskinesia 1 | MR1 (DYT8) | Blood with EDTA | 40 DAYS |
Dyslexia panel | CNTNAP | Blood with EDTA | 40 DAYS |
Dent Disease Type 2 | OCRL | Blood with EDTA | 40 DAYS |
Dent Disease Type 1 | CLCN5 | Blood with EDTA | 40 DAYS |
Neurodevelopmental Panel 1 | CNTNAP | Blood with EDTA | 30 DAYS |
Central Hypoventilation Syndrome | PHOX2B | Blood with EDTA | 30 DAYS |
Spastic Paralysis Type 3 | ATL1 | Blood with EDTA | 40 DAYS |
RPE Gene Screening | RPE65 | Blood with EDTA | 40 DAYS |
Pyridoxine - Dependent Epilepsy Antiguitin | ALDH7A1 | Blood with EDTA | 40 DAYS |
Noonan Syndrome Panel | PTPN11 | Blood with EDTA | 40 DAYS |
Limb - Girdle Muscular Distrophy, Autosomal Type 1E | DNAJB6 | Blood with EDTA | 40 DAYS |
Limb - Girdle Muscular Distrophy, Autosomal Type 1C | CAV3 | Blood with EDTA | 40 DAYS |
Limb - Girdle Muscular Distrophy, Autosomal Dominant Panel | MYO | Blood with EDTA | 40 DAYS |
Limb - Girdle Muscular D, Autosomal Recessive Type 2K | POMT1 | Blood with EDTA | 40 DAYS |
Legius Syndrome | SPRED1 | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Congenital Type 1A MLPA | LAMA2 | Blood with EDTA | 40 DAYS |
Coffin Lowry Syndrome | RPS6KA3 | Blood with EDTA | 40 DAYS |
Carasil Syndrome | HTRA1 | Blood with EDTA | 40 DAYS |
Amyotrophic Lateral Sclerosis (5 Exon) | SOD1 | Blood with EDTA | 40 DAYS |
Leukodystrophy | LMNB1 | Blood with EDTA | 40 DAYS |
DARS2 Sequence Analysis | DARS2 | Blood with EDTA | 40 DAYS |
Landau - Kleffner Syndrome | GRIN2A | Blood with EDTA | 40 DAYS |
Myoclonic Atonic Epilepsy | SLC6A1 | Blood with EDTA | 40 DAYS |
NF2 MLPA Deletion/Duplication Analyses | NF2 | Blood with EDTA | 40 DAYS |
NOG Whole Gene Sequence Analysis | NOG | Blood with EDTA | 40 DAYS |
Cortical Dysplasia TUBB3 Gene | TUBB3 | Blood with EDTA | 40 DAYS |
Parkinson's Disease PARK2 | PRKN | Blood with EDTA | 40 DAYS |
Pelizaeus - Merzbacher Disease | PLP1 | Blood with EDTA | 40 DAYS |
Periodic Hypokalemic Paralysis Type 2 (TG) SCN4A | SCN4A | Blood with EDTA | 40 DAYS |
Adrenoleukodystrophy (ALD) | ABCD1 | Blood with EDTA | 40 DAYS |
ARSACS (Spastic Ataxia of Charlevoix - Saguenay) SACS | SACS | Blood with EDTA | 40 DAYS |
Tuberosklerosis Panel | TSC | Blood with EDTA | 40 DAYS |
Neurofibromatosis Panel | NF | Blood with EDTA | 40 DAYS |
Crisponi Syndrome | CRLF1 | Blood with EDTA | 40 DAYS |
Episodic Ataxia, Type 5 | CACNB4 | Blood with EDTA | 40 DAYS |
Epileptic Encephalopathy, Early Infantile, 17 | GNAO1 | Blood with EDTA | 40 DAYS |
Marinesco - Sjogren Syndrome | SIL1 | Blood with EDTA | 40 DAYS |
Epileptic Encephalopathy, Early Infantile, 19 | GABRA1 | Blood with EDTA | 40 DAYS |
Epilepsy, Generalized, with Febrile Seizures Plus, Type 5 | GABRD | Blood with EDTA | 30 DAYS |
Emery - Dreifuss Muscular Dystrophy 1, X - Linked | EMD | Blood with EDTA | 30 DAYS |
Emery - Dreifuss Muscular Dystrophy 6, X - Linked | FHL1 | Blood with EDTA | 40 DAYS |
Brown - Vialetto - Van Laere Syndrome 1 | SLC52A3 | Blood with EDTA | 40 DAYS |
Spinal Muscular Atrophy Distal Type | IGHMBP2 | Blood with EDTA | 30 DAYS |
Canavan Disease | ASPA | Blood with EDTA | 30 DAYS |
Neurofibromatosis, Type 1 MLPA Deletion/Duplication Analysis | NF1 | Blood with EDTA | 30 DAYS |
Kaufman Oculocerebrofacial Syndrome | UBE3B | Blood with EDTA | 40 DAYS |
PRRT2 Whole Gene Sequence Analysis | PRRT2 | Blood with EDTA | 40 DAYS |
Limb - Girdle Muscular Dystrophy, Autosomal Recessive Panel 2 | CAPN | Blood with EDTA | 40 DAYS |
Griscelli Syndrome, Type 2 | RAB27 | Blood with EDTA | 40 DAYS |
Rett Syndrome | MECP2 | Blood with EDTA | 40 DAYS |
Brown - Vialetto - Van Laere Syndrome 2 | SLC52A2 | Blood with EDTA | 40 DAYS |
Leukoencephalopathy with Vanishing White Matter | EIF2B5 | Blood with EDTA | 40 DAYS |
Insensitivity to Pain, Congenital | NTRK1 | Blood with EDTA | 40 DAYS |
Myotubular Myopathy | MTM1 | Blood with EDTA | 40 DAYS |
Dystonia - 1, Torsion | TOR1A | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, FKRP Related | FKRP | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 2G | TCAP | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 2F | SGCD | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 2E | SGCB | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 2D | SGCA | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 1A | MYOT | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 1B | LMNA | Blood with EDTA | 40 DAYS |
Amyloidosis, Hereditary, Transthyretin Related | TTR | Blood with EDTA | 40 DAYS |
Limb - Girdle Muscular Dystrophy Panel 2 | CAV | Blood with EDTA | 40 DAYS |
Pyridoxamine 5 - Phosphate Oxidase Deficiency | PNPO | Blood with EDTA | 40 DAYS |
Lowe Syndrome | OCRL | Blood with EDTA | 40 DAYS |
Segawa Syndrome | TH | Blood with EDTA | 40 DAYS |
Epileptic Encephalopathy Type 13 | SCN8A | Blood with EDTA | 40 DAYS |
Mowat - Wilson Syndrome | ZEB2 | Blood with EDTA | 40 DAYS |
OPA1 Gene Analysis | OPA1 | Blood with EDTA | 40 DAYS |
Krabbe Disease | GALC | Blood with EDTA | 40 DAYS |
Hyperinsulinemic Hypoglycemia, Familial, 2 | KCNJ11 | Blood with EDTA | 40 DAYS |
Alstrom Syndrome | ALMS1 | Blood with EDTA | 40 DAYS |
Dystonia Type 4 | TUBB4A | Blood with EDTA | 40 DAYS |
Cornelia de Lange Syndrome 1 | NIPBL | Blood with EDTA | 41 DAYS |
Wolfram Syndrome 1 | WFS1 | Blood with EDTA | 40 DAYS |
Myasthenic Syndrome, Congenital, 6 | CHAT | Blood with EDTA | 40 DAYS |
Epidermolysis Bullosa Simplex Type 2 | KRT5 | Blood with EDTA | 40 DAYS |
Epilepsy, Progressive Myoclonic 1A (Unverricht and Lundborg) | CSTB | Blood with EDTA | 40 DAYS |
Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia | SRPX2 | Blood with EDTA | 40 DAYS |
Speech Language Disorder - 1 | FOXP2 | Blood with EDTA | 40 DAYS |
Dystonia 6, Torsion | THAP1 | Blood with EDTA | 40 DAYS |
Muscular Dystrophy Dystroglycanopathy (Limb - Girdle), Type C, 1 | POMT1 | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 2A | CAPN3 | Blood with EDTA | 40 DAYS |
Charcot Marie Tooth PMP22 Sequence Analysis | PMP22 | Blood with EDTA | 40 DAYS |
GLUT1 Deficiency Syndrome | SLC2A1 | Blood With EDTA | 40 DAYS |
PTEN Mutation Screening | PTEN | Blood with EDTA | 40 DAYS |
Myasthenic Syndrome, Congenital | CHRNE | Blood with EDTA | 40 DAYS |
Farber Disease | ASAH1 | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 2C | SGCG | Blood with EDTA | 40 DAYS |
Myotonia Congenita | CLCN1 | Blood with EDTA | 40 DAYS |
West Syndrome | ARX | Blood with EDTA | 40 DAYS |
Waardenburg Syndrome, Type 4A | EDNRB | Blood with EDTA | 40 DAYS |
Tuberous Sclerosis - 2 | TSC2 | Blood with EDTA | 40 DAYS |
Tuberous Sclerosis - 1 | TSC1 | Blood with EDTA | 40 DAYS |
TARP Syndrome | RBM10 | Blood with EDTA | 40 DAYS |
Spinocerebellar Ataxia Type 7 | ATXN7 | Blood with EDTA | 21 DAYS |
Spinocerebellar Ataxia Type 6 | CACNA1A | Blood with EDTA | 21 DAYS |
Spinocerebellar Ataxia Type 3 (Machado - Joseph Disease) | ATXN3 | Blood with EDTA | 21 DAYS |
Spinocerebellar Ataxia Type 2 | ATXN2 | Blood with EDTA | 21 DAYS |
Spinocerebellar Ataxia Type 1 | ATXN1 | Blood with EDTA | 21 DAYS |
Spinocerebellar Ataxia Panel | N/A | Blood with EDTA | 21 DAYS |
Spinal Muscular Atrophy (SMA) Point Mutation Analysis | SMN1 | Blood with EDTA | 40 DAYS |
Spinal Muscular Atrophy (SMA) MLPA | SMN1/ SMN2 | Blood with EDTA | 30 DAYS |
Spinal Muscular Atrophy (SMA) Deletion Analysis | SMN1 | Blood with EDTA | 21 DAYS |
Spastic Paraplegia 4, Autosomal Dominant | SPAST | Blood with EDTA | 40 DAYS |
Spastic Paraplegia 3A, Autosomal Dominant | ATL1 | Blood with EDTA | 40 DAYS |
Microphthalmia, Syndromic 3 | SOX2 | Blood with EDTA | 40 DAYS |
Waardenburg Syndrome | SOX10 | Blood with EDTA | 40 DAYS |
Microphthalmia, Syndromic 2 | BCOR | Blood with EDTA | 40 DAYS |
Rubinstein - Taybi Syndrome 1 (Broad Thumb - Hallux Syndrome) | CREBBP | Blood with EDTA | 40 DAYS |
Rett Syndrome, Congenital Variant | FOXG1 | Blood with EDTA | 40 DAYS |
Rett Syndrome | MECP2 | Blood with EDTA | 40 DAYS |
Epilepsy, Pyridoxine - Dependent (PDE) | ALDH7A1 | Blood with EDTA | 40 DAYS |
Prader Willi/Angelman Syndrome MLPA | 15q11-13 | Blood with EDTA | 30 DAYS |
Pantothenate Kinase - Associated Neurodegeneration (Hallervorden - Spatz Syndrome) | PANK2 | Blood with EDTA | 40 DAYS |
Pitt - Hopkins Syndrome | TCF4 | Blood with EDTA | 40 DAYS |
Pyruvate Dehydrogenase E1 - Alpha Deficiency | PDHA1 | Blood with EDTA | 40 DAYS |
Optic Atrophy 9 | ACO2 | Blood with EDTA | 40 DAYS |
Oculopharyngeal Muscular Dystrophy | PABPN1 | Blood with EDTA | 40 DAYS |
Odontoonychodermal Dysplasia | WNT10A | Blood with EDTA | 40 DAYS |
Ceroid Lipofuscinosis, Neuronal, 1 (Santavuori - Haltia Disease) | PPT1 | Blood with EDTA | 40 DAYS |
Ceroid Lipofuscinosis, Neuronal, 2 (Jansky Bielschowsky Disease) | TPP1 | Blood with EDTA | 40 DAYS |
Neurofibromatosis, Type 2 | NF2 | Blood with EDTA | 40 DAYS |
Neurofibromatosis, Type 1 (Von Recklinghausen Disease) | NF1 | Blood with EDTA | 40 DAYS |
Noonan Syndrome Type 4 | SOS1 | Blood with EDTA | 40 DAYS |
Noonan Syndrome Type 1 | PTPN11 | Blood with EDTA | 40 DAYS |
Myopathy, Myofibrillar, 1 | DES | Blood with EDTA | 40 DAYS |
Myopathy, Myosin Storage | MYH7 | Blood with EDTA | 40 DAYS |
Muckle - Wells Syndrome | NLRP3 | Blood with EDTA | 40 DAYS |
Myotonic Dystrophy 2 (Ricker Syndrome) | ZNF9 | Blood with EDTA | 21 DAYS |
Myotonic Dystrophy Type 1 (Steinert Disease) | DMPK | Blood with EDTA | 21 DAYS |
Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) Disease | TYMP | Blood with EDTA | 40 DAYS |
Mitochondrial Deletion Panel | MT - DNA | Blood with EDTA | 40 DAYS |
Mitochondrial Deletion Panel | MT - DNA | Blood with EDTA | 30 DAYS |
Mitochondrial Deletion Panel | MT - DNA | Blood with EDTA | 30 DAYS |
Mitochondrial Recessive Ataxia Syndrome | POLG | Blood with EDTA | 40 DAYS |
Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke - Like Episodes (MELAS) | MT - TL1 | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Limb - Girdle, Type 2B | DYSF | Blood with EDTA | 40 DAYS |
Leigh Syndrome | MT-DNA | Blood with EDTA | 40 DAYS |
Epilepsy, Progressive Myoclonic 2B (Lafora Disease) | NHLRC1 | Blood with EDTA | 40 DAYS |
Muscular Dystrophy, Congenital, (Partial LAMA2 Deficiency) | LAMA2 | Blood with EDTA | 40 DAYS |
Congenital Disorder of Glycosylation, Type Ia | PMM2 | Blood with EDTA | 40 DAYS |
Kennedy Disease | AR | Blood with EDTA | 40 DAYS |
Joubert Syndrome | NPHP3 | Blood with EDTA | 40 DAYS |
Joubert Syndrome 1 | INPP5E | Blood with EDTA | 40 DAYS |
Infantile Neuroaxonal Dystrophy 1 | PLA2G6 | Blood with EDTA | 40 DAYS |
Huntington Disease | HTT | Blood with EDTA | 21 DAYS |
Focal Dermal Hypoplasia (Goltz Syndrome) | PORCN | Blood with EDTA | 40 DAYS |
Freidreich Ataxia (FRDA) Analysis | FRDA | Blood with EDTA | 21 DAYS |
Friedreich Ataxia Analysis | FXN | Blood with EDTA | 40 DAYS |
Fragile X Syndrome | FMR1 | Blood with EDTA | 21 DAYS |
Epileptic Encephalopathy, Early Infantile, 2 | CDKL5 | Blood with EDTA | 40 DAYS |
Duchenne Muscular Dystrophy Whole Gene Deletion / Carrier Analysis | DMD | Blood With EDTA | 30 DAYS |
Duchenne Muscular Dystrophy 21 Exome Deletion Analysis | DMD | Blood with EDTA | 21 DAYS |
Duchenne Muscular Dystrophy Whole Gene Analysis | DMD | Blood With EDTA | 40 DAYS |
Epileptic Encephalopathy, Early Infantile, 6 (Dravet Syndrome) | SCN1A | Blood with EDTA | 40 DAYS |
Charcot Marie Tooth MPZ Analysis | MPZ | Blood with EDTA | 40 DAYS |
Charcot Marie Tooth MFN2 Analysis | MFN2 | Blood with EDTA | 40 DAYS |
Charcot Marie Tooth Disease Deletion Duplication Analysis | MFN | Blood with EDTA | 30 DAYS |
Charcot Marie Tooth Disease, Type 1A | PMP22 | Blood with EDTA | 30 DAYS |
Charcot Marie Tooth Neuropathy, X - Linked Dominant, 1 | GJB1 | Blood with EDTA | 30 DAYS |
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL Syndrome) | NOTCH3 | Blood with EDTA | 40 DAYS |
Ataxia, Early Onset with Oculomotor Apraxia and Hypoalbuminemia | APTX | Blood with EDTA | 40 DAYS |
Ataxia Telangiectasia | ATM | Blood with EDTA | 40 DAYS |
Alexander Disease | GFAP | Blood with EDTA | 40 DAYS |
Myelofibrosis, Somatic | CALR | Blood with EDTA | 21 DAYS |
Megalencephalic Leukoencephalopathy | MLC1 | Blood with EDTA | 40 DAYS |
Wolf-Hirchhorn Syndorme - 4p16 Deletion WHSC1 | N/A | Heparinized Blood | 7 DAYS |
Williams Syndrome - 7q11.23 Deletion | N/A | Heparinized Blood / Bone Marrow | 7 DAYS |
DiGeorge Syndrome | -1 | -1 | 7 DAYS |
Cri du Chat Syndrome | -1 | Heparinized Blood | 15 DAYS |
Angelman Syndrome MLPA | 15q11-13 | Blood with EDTA | 40 DAYS |
Kallmann Syndrome (KAL1 gene Deletion Del Xp22.3) | KAL1 | Heparinized Blood | 7 DAYS |
FISH (X, Y) | N/A | Heparinized Blood | 7 DAYS |
Rapid Aneuploidy Analysis Panel 2 from Amniotic Fluid (FISH/13, 18, 21, X, Y) | N/A | Amniotic Fluid | 3 DAYS |
Rapid Aneuploidy Analysis Panel 1 from Amniotic Fluid (FISH/13, 18, 21) | N/A | Amniotic Fluid | 3 DAYS |
Rapid Aneuploidy Analysis Panel from Cord Blood (FISH/13, 18, 21) | N/A | Cord Blood | 3 DAYS |
Rapid Aneuploidy Analysis Panel from Chorionic Villus Material (FISH/13, 18, 21) | N/A | Chorionic Villus | 3 DAYS |
Chromosome Analysis from Skin Biopsy Material | N/A | Skin Biopsy | 28 DAYS |
Chromosome Analysis from Cordosynthesis Material | N/A | Cord Blood | 15 DAYS |
Chromosome Analysis from Peripheral Blood | N/A | Heparinized Blood | 21 DAYS |
Chromosome Analysis from Chorionic Villus | N/A | Chorionic Villus | 28 DAYS |
Chromosome Analysis from Amniotic Fluid | N/A | Amniotic Fluid | 21 DAYS |
Prader Willi/Angelman Syndrome | SNRPN | Heparinized Blood / Bone Marrow | 30 DAYS |
FISH Analysis for Chromosomal Disorders | N/A | Bone Marrow / Heparinized Blood / Blood with EDTA | 21 DAYS |
1q21 (CKS1B)/ 1p32.3[CDKN2C (P18)] | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
11q22.3 Deletion | N/A | Heparinized Blood | 7 DAYS |
Iron Refractory Iron Deficiency Anemia | TMPRSS6 | Blood with EDTA | 30 DAYS |
Bernard Soulier Syndrome | GP1B | Blood with EDTA | 30 DAYS |
Diamond-Blackfan anemia 6 | RPL5 | Blood with EDTA | 30 DAYS |
t(6;14)(p21;q32) | N/A | Heparinized Blood / Bone Marrow | 21 DAYS |
t(14;20)(q32;q12) | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
SCE (Sister Chromatid Exchange) | N/A | Heparinized Blood | 15 DAYS |
Philadelphia Chromosome FISH Analysis | N/A | Heparinized Blood / Bone Marrow | 21 DAYS |
Pediatric MDS Panel | N/A | Bone Marrow / Heparinized Blood | 7 DAYS |
Pediatric AML Panel | N/A | Bone Marrow / Heparinized Blood | 7 DAYS |
Pediatric ALL Panel | N/A | Bone Marrow / Heparinized Blood | 7 DAYS |
Non-Hodgkin Lymphome Panel | N/A | Bone Marrow / Heparinized Blood | 7 DAYS |
Monosomy / Trisomy 11 | N/A | Heparinized Blood | 7 DAYS |
MM Panel | N/A | Bone Marrow / Heparinized Blood | 21 DAYS |
MDS Panel | N/A | Bone Marrow / Heparinized Blood | 7 DAYS |
KML Panel | N/A | Heparinized Blood / Bone Marrow | 7 DAYS |
KLL Panel | N/A | Heparinized Blood / Bone Marrow | 7 DAYS |
Chromosome Analysis from Bone Marrow | N/A | Bone Marrow | 21 DAYS |
inv (16) Quantitative FISH | -1 | Heparinized Blood | 21 DAYS |
FGFR FISH | -1 | Heparinized Blood / Bone Marrow | 21 DAYS |
DEB Analysis Diepoxybutane Test | -1 | Heparinized Blood / Bone Marrow / Skin Biopsy | 15 DAYS |
AML Panel | N/A | Bone Marrow / Heparinized Blood | 7 DAYS |
ALL Panel | N/A | Bone Marrow / Heparinized Blood | 7 DAYS |
Congenital Dyserythropoietic Anemia Type 1A | CDAN1 | Blood with EDTA | 30 DAYS |
Systemic Lupus Erythematosus | TREX1 | Blood with EDTA | 40 DAYS |
HLA A,B,DR SSP Analyses | N/A | Blood with EDTA | 40 DAYS |
HLA B27 | N/A | Blood with EDTA | 40 DAYS |
FMF (Familial Mediterranean Fever) (Exon 1, 4, 6, 7, 8, 9) | MEFV | Blood with EDTA | 40 DAYS |
FMF (Familial Mediterranean Fever) (Exon 2, 3, 5, 10) | MEFV | Blood with EDTA | 40 DAYS |
Neutropenia, severe congenital 4 | G6PC3 | Blood with EDTA | 30 DAYS |
Congenital Neutropenia Panel | HAX | Blood with EDTA | 30 DAYS |
Thrombocytopenia 5 | ETV6 | Blood with EDTA | 40 DAYS |
Macrothrombocytopenia | MYH9 | Blood with EDTA | 40 DAYS |
Methemoglobinemia, Type I | CYB5R3 | Blood with EDTA | 40 DAYS |
Von Willebrand Disease Whole Gene | VWF | Blood with EDTA | 30 DAYS |
Bruton Agammaglobulinemia | IBTK | Blood with EDTA | 40 DAYS |
Thrombotic Thrombocytopenic Purpura | ADAMTS13 | Blood with EDTA | 40 DAYS |
Hyper - IgE Recurrent Infection Syndrome | DOCK8 | Blood with EDTA | 40 DAYS |
Acute Myeloid Leukemia NPM1 Gene Exon 9 | NPM1 | Blood with EDTA | 40 DAYS |
Hyper - IgE Recurrent Infection Syndrome | STAT3 | Blood with EDTA | 40 DAYS |
Wiskott - Aldrich Syndrome | WAS | Blood with EDTA | 40 DAYS |
Periodic Fever Syndrome (TRAPS) | TNFRSF1A | Blood with EDTA | 40 DAYS |
Periodic Fever Syndrome (CAPS1) | NLRP3 | Blood with EDTA | 40 DAYS |
Periodic Fever Syndrome | SPAG7 | Blood with EDTA | 40 DAYS |
Afibrinogenemia, Congenital, Gamma (FGG) | FGG | Blood with EDTA | 40 DAYS |
Afibrinogenemia,Congenital, Beta (FGB) | FGB | Blood with EDTA | 40 DAYS |
Afibrinogenemia, Congenital, Alpha (FGA) | FGA | Blood with EDTA | 40 DAYS |
Neutropenia, Severe Congenital 1 | ELANE | Blood with EDTA | 40 DAYS |
Neutropenia, Severe Congenital 3 | HAX1 | Blood with EDTA | 40 DAYS |
Angioedema, Hereditary, Type III | F12 | Blood with EDTA | 40 DAYS |
Angioedema, Hereditary, Types I and II | SERPING1 | Blood with EDTA | 40 DAYS |
Hemolytic Uremic Syndrome, Atypical, Susceptibility to, 1 | CFH | Blood with EDTA | 40 DAYS |
Celiac Disease | HLA - D | Blood with EDTA | 21 DAYS |
Behcet Syndrome | HLA - B51 | Blood with EDTA | 21 DAYS |
7q31 Deletion | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
8q24 (MYC) Rearrangements | MYC | Heparinized Blood / Bone Marrow | 15 DAYS |
4q12 Deletion | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
11q23 Deletion | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
11q22 Deletion | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
13q14.3 Deletion - D13S319 Deletion | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
13q34 Deletion | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
20q12 Deletion | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
17p13.1 Deletion (p53) | TP53 | Heparinized Blood / Bone Marrow | 15 DAYS |
8p12 Deletion (FGFR1) | FGFR1 | Heparinized Blood / Bone Marrow | 15 DAYS |
5q31 Deletion (EGR1) | EGR1 | Heparinized Blood / Bone Marrow | 15 DAYS |
5q33 Deletion (PDGFRB) | PDGFRB | Heparinized Blood | 15 DAYS |
Monosomy/Trisomy 4 | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
Monosomy/Trisomy 10 | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
Monosomy/Trisomy 12 | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
Monosomy/Trisomy 5 | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
Monosomy/Trisomy 8 | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
Monosomy/Trisomy 7 | N/A | Heparinized Blood / Bone Marrow | 15 DAYS |
t(14;16) (q32;q21) | IGH/MALT1 | Heparinized Blood / Bone Marrow | 15 DAYS |
t(9;11) (p22;q23) | KMT2A/MLLT3 | Heparinized Blood / Bone Marrow | 15 DAYS |
t(4;11) (q21;q23) MLL - AF4 Fusion | MLL/AF4 | Heparinized Blood / Bone Marrow | 15 DAYS |
inv(16) (p13;q22)/t(16;16) (p13;q22) CBFB Gene | CBFB | Heparinized Blood / Bone Marrow | 15 DAYS |
t(8;14) (q24;q32) MYC - IGH Fusion | MYC - IGH | Heparinized Blood / Bone Marrow | 15 DAYS |
t(14;18) (q32;q21) IGH/BCL2 Fusion | IGH/BCL2 | Heparinized Blood / Bone Marrow | 15 DAYS |
t(12;21) (p13;q22) ETV6 (TEL)/RUNX1 (AML1) Fusion | ETV6(TEL)/RUNX1(AML1) | Heparinized Blood / Bone Marrow | 15 DAYS |
t(4;14) (q16;q32) FGFR3/IGH Fusion | FGFR3/IGH | Heparinized Blood / Bone Marrow | 15 DAYS |
t(1;19) )(q23;p13.3) TCF3/PBX1 | TCF3/PBX1 | Heparinized Blood / Bone Marrow | 15 DAYS |
t(11;14) (q13;q32) CCND1/IGH Fusion | CCND1/IGH | Heparinized Blood / Bone Marrow | 15 DAYS |
t(15;17) (q22;q21) PML/RARA Fusion | PML/RARA | Heparinized Blood / Bone Marrow | 15 DAYS |
t(8;21) (q22;q22) | ETO/AML1 | Heparinized Blood / Bone Marrow | 15 DAYS |
t(9;22) (q34;q11.2 ) BCR - ABL Fusion | BCR/ABL | Heparinized Blood / Bone Marrow | 15 DAYS |
Thrombocytopenia, X - Linked | GATA1 | Blood with EDTA | 40 DAYS |
t(8;21) Real Time PCR | RUNX - AML | Blood with EDTA | 21 DAYS |
t(12;21) TEL/AML1 Real Time PCR | TEL/AML1 | Blood with EDTA | 21 DAYS |
t(1;19) E2A/PBX1 Real Time PCR | E2A/PBX1 | Blood with EDTA | 21 DAYS |
t (15;17) Real Time PCR | PML - RARA | Blood with EDTA | 21 DAYS |
t(9;22) Real Time PCR (BCR-ABL p210) | BCR - ABL P210 | Blood with EDTA | 21 DAYS |
t(9;22) Real Time PCR (BCR-ABL p190) | BCR - ABL P190 | Blood with EDTA | 21 DAYS |
Inversion 16 Real Time PCR | CBFB - MYH11 | Blood with EDTA | 21 DAYS |
PDGFRA Gene Mutation Analysis | PDGFRB | Blood with EDTA / Paraffin Block | 40 DAYS |
Sickle Cell Anemia | HBB | Blood with EDTA | 21 DAYS |
Dyserythropoietic Anemia, Congenital, Type II | SEC23B | Blood with EDTA | 40 DAYS |
Chimerism, Post-Transplantation | N/A | Blood with EDTA | 21 DAYS |
Chimerism, Pre-Transplantation, Donor | N/A | Blood with EDTA | 21 DAYS |
Chimerism, Pre-Transplantation, Receiver | N/A | Blood with EDTA | 21 DAYS |
Chimerism (FISH) | N/A | Heparinized Blood | 7 DAYS |
Chimerism (Molecular) | N/A | Blood with EDTA | 21 DAYS |
JAK 2 Real Time PCR | JAK2 | Blood with EDTA | 21 DAYS |
JAK 2 Gene Mutation Analysis (V617F) | JAK2 | Blood with EDTA | 21 DAYS |
JAK 2 Gene Exon 12 Mutation Analyses | JAK2 | Blood with EDTA | 21 DAYS |
Hemophagocytic Lymphohistiocytosis, Familial, 5 | STXBP2 | Blood with EDTA | 40 DAYS |
Hemophagocytic Lymphohistiocytosis, Familial, 4 | STX11 | Blood with EDTA | 40 DAYS |
Hemophagocytic Lymphohistiocytosis, Familial, 3 | MUN13 (UNC13D) | Blood with EDTA | 40 DAYS |
Hemophagocytic Lymphohistiocytosis, Familial, 2 | PRF1 | Blood with EDTA | 40 DAYS |
Spherocytosis | ANK1 | Blood with EDTA | 40 DAYS |
Hemophilia B | F9 | Blood with EDTA | 40 DAYS |
Hemophilia A | F8 | Blood with EDTA | 40 DAYS |
Beta Thalassemia | HBB | Blood with EDTA | 21 DAYS |
Amegakaryocytic Thrombocytopenia Common Mutation Screening | MPL (S505N W515L K39N) | Blood with EDTA | 21 DAYS |
Alpha Thalassemia Whole Gene Sequencing | HBA1/HBA2 | Blood with EDTA | 40 DAYS |
Alpha Thalassemia Deletion Analysis | HBA | Blood with EDTA | 21 DAYS |
Leukemia, Acute Myeloid | NPM1 | Blood with EDTA | 21 DAYS |
Leukemia, Acute Myeloid | CEBPA | Blood with EDTA | 21 DAYS |
Periodic Fever Syndrome Panel Group 1 | MEFV | Blood with EDTA | 40 DAYS |
Retinoblastoma | RB1 | Blood with EDTA | 40 DAYS |
Noonan Syndrome Panel | PTPN11 | Blood with EDTA | 40 DAYS |
Microsatellite Instability (MSI) | 5 Marker | Blood with EDTA | 40 DAYS |
Peutz - Jeghers Syndrome | STK11 | Blood with EDTA | 40 DAYS |
Multiple Endocrine Neoplasia Type 1 | MEN1 | Blood with EDTA | 40 DAYS |
Inherited Breast/Ovarian Cancer Panel | PTE | Blood with EDTA | 40 DAYS |
HRAS Sequence Analysis | HRAS | Blood with EDTA | 40 DAYS |
Macroglobulinemia, Waldenstrom | MYD88 | Blood with EDTA | 40 DAYS |
Beckwith - Wiedemann Syndrome | CDKN1C | Blood with EDTA | 40 DAYS |
Colon Cancer Panel | KRA | Blood with EDTA | 40 DAYS |
CLOVE Syndrome, Somatic | PIK3CA | Blood with EDTA | 40 DAYS |
Loeys-Dietz Syndrome 2 | TGFBR2 | Blood with EDTA | 40 DAYS |
BRCA1/BRCA2 MLPA | BRCA1/BRCA2 | Blood with EDTA / Paraffin Block | 21 DAYS |
Gorlin - Goltz Syndrome | SUFU | Blood with EDTA | 40 DAYS |
Peutz - Jeghers Syndrome STK11 MLPA | STK11 | Blood with EDTA | 21 DAYS |
Retinoblastoma MLPA | RB1 | Blood with EDTA | 21 DAYS |
Lynch Syndrome/Colorectal Cancer, Hereditary Nonpolyposis, Type 5 MSH6 MLPA | MSH6 | Blood with EDTA | 40 DAYS |
Lynch Syndrome/HNPCC Panel 1 | MLH1/ MSH2 | Blood With EDTA | 40 DAYS |
Lynch Syndrome (HNPCC) Panel | MLH | Blood with EDTA | 40 DAYS |
Lynch Syndrome/Colorectal Cancer, Hereditary Nonpolyposis, Type 4 PMS2 MLPA | PMS2 | Blood with EDTA | 21 DAYS |
PTEN Mutation Screening | PTEN | Blood with EDTA | 40 DAYS |
MLH1/MSH2 MLPA | MLH1/MSH2 | Blood with EDTA | 21 DAYS |
Von Hippel - Lindau Syndrome (VHL) | VHL | Blood with EDTA | 40 DAYS |
Noonan Syndrome Type 1 | PTPN11 | Blood with EDTA | 40 DAYS |
Multiple Endocrine Neoplasia, Type IV | CDKN1B | Blood with EDTA | 40 DAYS |
Basal Cell Nevus Syndrome (Gorlin Syndrome) | PTCH1 | Blood with EDTA | 40 DAYS |
Warfarin Resistance and Warfarin Sensitivity | VKORC | Blood with EDTA | 30 DAYS |
ROS1 Deletion (6q22.1) | ROS1 | Paraffin Block | 15 DAYS |
ALK Deletion (2p23) | ALK | Bone Marrow / Paraffin Block | 15 DAYS |
HER2/NEU (ERBB2) FISH | HER2/NEU(ERBB2) | Paraffin Block | 15 DAYS |
17p13.1 Deletion (p53) | TP53 | Heparinized Blood / Bone Marrow | 15 DAYS |
Wilms Tumor, Type 1 | WT1 | Blood with EDTA / Paraffin Block | 40 DAYS |
TPMT Gene Common Mutation Analysis | TPMT (238G> | Blood with EDTA | 40 DAYS |
TP53 Gene Screening | TP53 | Blood with EDTA / Paraffin Block | 40 DAYS |
PDGFRA Gene Common Mutation Exon 12.18 | PDGFRA | Blood with EDTA / Paraffin Block | 40 DAYS |
NRAS Gene Mutation Panel | NRAS | Blood with EDTA / Paraffin Block | 21 DAYS |
Myelofibrosis, Somatic | CALR | Blood with EDTA | 21 DAYS |
Multiple Endocrine Neoplasia IIA | RET | Blood with EDTA | 40 DAYS |
Microsatellite Instability (MSI) | 5 Marker | Paraffin Block | 21 DAYS |
MDR1 Gene Polymorphisms Screening | MDR1 | Blood with EDTA | 21 DAYS |
Lynch Syndrome / Colorectal Cancer, Hereditary Nonpolyposis, Type 4 | PMS2 | Blood with EDTA | 40 DAYS |
Lynch Syndrome / Colorectal Cancer, Hereditary Nonpolyposis, Type 3 | PMS1 | Blood with EDTA | 40 DAYS |
Lynch Syndrome / Colorectal Cancer, Hereditary Nonpolyposis, Type 5 | MSH6 | Blood with EDTA | 40 DAYS |
Lynch Syndrome / Colorectal Cancer, Hereditary Nonpolyposis, Type 2 | MLH1 | Blood with EDTA | 40 DAYS |
Lynch Syndrome / Colorectal Cancer, Hereditary Nonpolyposis, Type 1 | MSH2 | Blood with EDTA | 40 DAYS |
JAK 2 Gene Mutation Analysis (V617F) | JAK2 | Blood with EDTA | 21 DAYS |
JAK 2 Gene Exon 12 Mutation Analyses | JAK2 | Blood with EDTA | 21 DAYS |
Leukemia, Philadelphia Chromosome - Positive, Resistant to Imatinib | ABL1 | Blood with EDTA | 21 DAYS |
FLT3 Gene Mutation Analysis | FLT3 | Blood with EDTA | 21 DAYS |
Colorectal Adenomatous Polyposis | APC | Blood with EDTA | 40 DAYS |
Colorectal Adenomatous Polyposis | MUTYH | Blood with EDTA | 40 DAYS |
EGFR Mutation Panel | EGFR | Blood with EDTA / Paraffin Block | 21 DAYS |
C - KIT Gene Common Mutation Exon 9, 11, 13 and 17 | C - KIT | Bone Marrow / Paraffin Block | 21 DAYS |
BRCA2 Gene Mutation | BRCA2 | Blood with EDTA | 40 DAYS |
BRCA1 Gene Mutation | BRCA1 | Blood with EDTA | 40 DAYS |
BRCA1/2 Gene Mutation - Breast Cancer | BRCA1/BRCA2 | Blood with EDTA | 40 DAYS |
BRCA2 Gene MLPA (Deletion Duplication Analysis) | BRCA2 | Blood with EDTA | 40 DAYS |
BRCA1 Gene MLPA (Deletion Duplication Analysis) | BRCA1 | Blood with EDTA | 30 DAYS |
BRAF Gene Mutation Analysis | BRAF | Blood with EDTA / Paraffin Block | 21 DAYS |
KRAS Gene Mutation Panel | KRAS | Paraffin Block | 21 DAYS |
Hypercholesterolemia, Familial, 3 | PCSK9 | Blood with EDTA | 40 DAYS |
Sitosterolemia | ABCG5 | Blood with EDTA | 30 DAYS |
Pyruvate kinase deficiency | PKLR | Blood with EDTA | 30 DAYS |
Hyperglycinemia, Lactic Acidosis and Seizures | LIAS | Blood with EDTA | 30 DAYS |
Lipoprotein A (LPA Exon 21-39) Panel 2 | LPA | Blood with EDTA | 40 DAYS |
Lipoprotein A (LPA Exon 1-20) Panel 1 | LPA | Blood with EDTA | 40 DAYS |
Cystinuria | SLC3A1 | Blood with EDTA | 30 DAYS |
Cerebral Creatine Deficiency Syndrome 2 | GAMT | Blood with EDTA | 30 DAYS |
Neurodegeneration due to cerebral folate transport deficiency | FOLR1 | Blood with EDTA | 30 DAYS |
Transcobalamin II Deficiency | TCN2 | Blood with EDTA | 40 DAYS |
Short Chain AD Deficiency | ACADS | Blood with EDTA | 40 DAYS |
FAR1 | FAR1 | Blood with EDTA | 40 DAYS |
Galactosemia Type 2 (GALK1 Whole Gene Analysis) | GALK1 | Blood with EDTA | 40 DAYS |
Fructose Intolerance (ALDOB Whole Gene Analysis) | ALDOB | Blood with EDTA | 40 DAYS |
DARS2 Sequence Analysis | DARS2 | Blood with EDTA | 40 DAYS |
Glutaric Acidemia Type 2 Panel | ETF | Blood with EDTA | 40 DAYS |
Mukopolipidosis Panel | ARS | Blood with EDTA | 40 DAYS |
Dihydropyrimidine Dehydrogenase Deficiency | DPYD | Blood with EDTA | 40 DAYS |
Hypertriglyceridemia | APOA5 | Blood with EDTA | 40 DAYS |
Hyperlipoproteinemia LPL Gene | LPL | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease Type 9D (PHKA1 TG) | PHKA1 | Blood with EDTA | 40 DAYS |
Glutaric Acidemia Type 2C (ETFDH Whole Gene Sequence) | ETFDH | Blood with EDTA | 40 DAYS |
Hemacromatosis Panel | HF | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease Panel | G6P | Blood with EDTA | 40 DAYS |
Carnitine Palmitoyltransferase IA Deficiency | CPT1A | Blood with EDTA | 40 DAYS |
Hyperinsulinemic Hypoglycemia, Familial, 4 | HADH | Blood with EDTA | 40 DAYS |
Chanarin - Dorfman Syndrome | ABHD5 | Blood with EDTA | 40 DAYS |
17 - Beta Hydroxysteroid Dehydrogenase 1 Deficiency | HSD17B1 | Blood with EDTA | 40 DAYS |
Molybdenum Cofactor Deficiency A | MOCS1 | Blood with EDTA | 40 DAYS |
Obesity, Morbid, Type 2 | LEPR | Blood with EDTA | 40 DAYS |
Obesity, Morbid | LEP | Blood with EDTA | 30 DAYS |
Thiamine Metabolism Dysfunction Syndrome 2 | SLC19A3 | Blood with EDTA | 30 DAYS |
Canavan Disease | ASPA | Blood with EDTA | 30 DAYS |
FH Gene Screening | FH | Blood with EDTA | 30 DAYS |
Maple Syrup Urine Disease, Type II | DBT | Blood with EDTA | 40 DAYS |
Tyrosinemia, Type I | FAH | Blood with EDTA | 40 DAYS |
Riboflavin Transporter Deficiency | SLC52A1 | Blood with EDTA | 40 DAYS |
Lisosomal Disease Panel | ARS | Blood with EDTA | 40 DAYS |
Homocystinuria | CBS | Blood with EDTA | 40 DAYS |
Antley - Bixler Syndrome | POR | Blood with EDTA | 40 DAYS |
Monocarboxylate Transporter 1 Deficiency | SLC16A1 | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type VI (Maroteaux - Lamy) | ARSB | Blood with EDTA | 40 DAYS |
Pseudohypoaldosteronism, Type I | SCNN1A | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease IV | GBE1 | Blood with EDTA | 40 DAYS |
Mucolipidosis III Gamma | GNPTG | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IIID | GNS | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis VII | GUSB | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IIIC (Sanfilippo C) | HGSNAT | Blood with EDTA | 40 DAYS |
Pyridoxamine 5 - Phosphate Oxidase Deficiency | PNPO | Blood with EDTA | 40 DAYS |
Glutaricaciduria, Type I | GCDH | Blood with EDTA | 40 DAYS |
Niemann - Pick Disease, Type C1 | NPC1 | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease Type 5 | PYGM | Blood with EDTA | 40 DAYS |
Obesity, Adrenal Insufficiency | POMC | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease Type 9B | PKHB | Blood with EDTA | 41 DAYS |
Bloom Syndrome | BLM | Blood with EDTA | 40 DAYS |
Sandhoff Disease | HEXB | Blood with EDTA | 40 DAYS |
Krabbe Disease | GALC | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease Type 9 | PHKA | Blood with EDTA | 40 DAYS |
Berardinelli Syndrome | AGPAT2 | Blood with EDTA | 40 DAYS |
Hyperinsulinemic Hypoglycemia, Familial, 2 | KCNJ11 | Blood with EDTA | 40 DAYS |
Phenylketonuria | PAH | Blood with EDTA | 40 DAYS |
Alstrom Syndrome | ALMS1 | Blood with EDTA | 40 DAYS |
Megdel Syndrome | SERAC1 | Blood with EDTA | 40 DAYS |
Acyl - CoA Dehydrogenase, Medium Chain | ACADM | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease VI | PYGL | Blood with EDTA | 40 DAYS |
Surfactant Metabolism Dysfunction, Pulmonary, 1 | SFTPB | Blood with EDTA | 40 DAYS |
Nonketotic Hyperglycinemia | GLDC | Blood with EDTA | 40 DAYS |
Nonketotic Hyperglycinemia | AMT | Blood with EDTA | 40 DAYS |
GLUT1 Deficiency Syndrome | SLC2A1 | Blood With EDTA | 40 DAYS |
Mucolipidosis II Alpha/Beta | GNPTAB | Blood with EDTA | 40 DAYS |
Farber Disease | ASAH1 | Blood with EDTA | 40 DAYS |
Argininemia | ARG1 | Blood with EDTA | 40 DAYS |
Peroxisome Biogenesis Disorder 1A (Zellweger) | PEX1 | Blood with EDTA | 40 DAYS |
Wilson Disease | ATP7B | Blood with EDTA | 40 DAYS |
Tay - Sachs Disease (Hexosaminidase A Deficiency) | HEXA | Blood with EDTA | 40 DAYS |
Smith Lemli Opitz Syndrome | DHCR7 | Blood with EDTA | 40 DAYS |
Cystinosis | CTNS | Blood with EDTA | 40 DAYS |
Sialidosis, Type I | NEU1 | Blood with EDTA | 40 DAYS |
Pompe Disease | GAA | Blood with EDTA | 40 DAYS |
Pyruvate Dehydrogenase E1 - Alpha Deficiency | PDHA1 | Blood with EDTA | 40 DAYS |
Periodic Fever Syndrome (TRAPS) | TNFRSF1A | Blood with EDTA | 40 DAYS |
Niemann - Pick Disease Type A, Type B (Sphingomyelinase Deficiency) | SMPD1 | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IIIB (Sanfilippo B) | NAGLU | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IVA (Morquio Syndrome) | GALNS | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome A) | SGSH | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type II (Hunter Syndrome) | IDS | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type 1H (Hurler Syndrome) | IDUA | Blood with EDTA | 40 DAYS |
Methylmalonic Aciduria, MUT (0) Type | MUT | Blood with EDTA | 40 DAYS |
Metachromatic Leukodystrophy | ARSA | Blood with EDTA | 40 DAYS |
Menkes Disease (Kınky Hair Disease) | ATP7A | Blood with EDTA | 40 DAYS |
Maple Syrup Urine Disease, Type Ib | BCKDHB | Blood with EDTA | 40 DAYS |
Maple Syrup Urine Disease, Type Ia | BCKDHA | Blood with EDTA | 40 DAYS |
Congenital Disorder of Glycosylation, Type Ia | PMM2 | Blood with EDTA | 40 DAYS |
Carnitine Palmitoyl transferase 2 Deficiency | CPT2 | Blood with EDTA | 40 DAYS |
Familial Hypertriglyceridemia | LIPI | Blood with EDTA | 40 DAYS |
Hyperoxaluria, Primary, Type 1 (Alanine Glyoxylate Aminotransferase Deficiency) | AGTX | Blood with EDTA | 40 DAYS |
Hyperinsulinemic Hypoglycemia, Familial, 1 | ABCC8 | Blood with EDTA | 40 DAYS |
Hyper - IgD Syndrome (Mevalonate Kinase Deficiency) | MVK | Blood with EDTA | 40 DAYS |
Hemochromatosis | HFE | Blood with EDTA | 40 DAYS |
Hemochromatosis, Type 3 | TFR2 | Blood with EDTA | 40 DAYS |
Glucose - 6 - Phosphate Dehydrogenase Deficiency | G6PD | Blood with EDTA | 40 DAYS |
Glucose Galactose Malabsorption | SLC5A1 | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease IIIb, IIIa (Cori Disease) | AGL | Blood with EDTA | 40 DAYS |
Glycogen Storage Disease Type 1a (von Gierke Disease) | G6PC | Blood with EDTA | 40 DAYS |
Gaucher Disease | GBA | Blood with EDTA | 40 DAYS |
GM1 - Gangliosidosis, Type I, Type II, Type III (β - Galactosidase Deficiency) | GLB1 | Blood with EDTA | 40 DAYS |
Galactosemia (Galactose - 1 Phosphate Uridylyltransferase Deficiency) | GALT | Blood with EDTA | 40 DAYS |
Friedreich Ataxia Analysis | FXN | Blood with EDTA | 40 DAYS |
Fish Eye Disease | LCAT | Blood with EDTA | 40 DAYS |
Phenylketonuria | PAH | Blood with EDTA | 40 DAYS |
Fanconi Bickel Syndrome | SLC2A2 | Blood with EDTA | 40 DAYS |
Fabry Disease | GLA | Blood with EDTA | 40 DAYS |
CYP2C19 Polymorphisms Screening | CYP2C19 | Blood with EDTA | 40 DAYS |
Biotinidase Deficiency | BTD | Blood with EDTA | 40 DAYS |
APOE Genotyping | APOE (Leu167Del) | Blood with EDTA | 30 DAYS |
Hypercholesterolemia, Familial | LDLR | Blood with EDTA | 40 DAYS |
Periodic Fever Syndrome Panel Group 1 | MEFV | Blood with EDTA | 40 DAYS |
Non-Invasive Fetal DNA Analysis | N/A | Cell-Free DNA BCT Blood Tube | 10 DAYS |
BPES Disease | FOXL2 | Blood with EDTA | 40 DAYS |
Prenatal Maternal Contamination Test | N/A | Blood with EDTA | 40 DAYS |
LHCGR GENE POLYMORPHISM SCREENING | LHCGR | Blood with EDTA | 40 DAYS |
LH Gene Polymorphism Analysis | LHB | Blood with EDTA | 20 DAYS |
Persistent Mullerian Duct Syndrome | AMH | Blood with EDTA | 40 DAYS |
Protein C Deficiency | PROC | Blood with EDTA | 40 DAYS |
Kallmann Syndrome (KAL1 gene Deletion Del Xp22.3) | KAL1 | Heparinized Blood | 7 DAYS |
FISH (X, Y) | N/A | Heparinized Blood | 7 DAYS |
Rapid Aneuploidy Analysis Panel 2 from Amniotic Fluid (FISH/13, 18, 21, X, Y) | N/A | Amniotic Fluid | 3 DAYS |
Rapid Aneuploidy Analysis Panel 1 from Amniotic Fluid (FISH/13, 18, 21) | N/A | Amniotic Fluid | 3 DAYS |
Rapid Aneuploidy Analysis Panel from Cord Blood (FISH/13, 18, 21) | N/A | Cord Blood | 3 DAYS |
Rapid Aneuploidy Analysis Panel from Chorionic Villus Material (FISH/13, 18, 21) | N/A | Chorionic Villus | 3 DAYS |
Chromosome Analysis from Abort Material | N/A | Abort Material | 28 DAYS |
Chromosome Analysis from Cordosynthesis Material | N/A | Cord Blood | 15 DAYS |
Chromosome Analysis from Peripheral Blood | N/A | Heparinized Blood | 21 DAYS |
Chromosome Analysis from Chorionic Villus | N/A | Chorionic Villus | 28 DAYS |
Chromosome Analysis from Amniotic Fluid | N/A | Amniotic Fluid | 21 DAYS |
Thrombophilia Panel (6 Mutations) | MTHF | Blood with EDTA | 15 DAYS |
Thrombophilia Panel (4 Mutations) | MTHF | Blood with EDTA | 15 DAYS |
Plasminogen Activator Inhibitor - 1 Deficiency | PAI | Blood with EDTA | 15 DAYS |
MTHFR C677T Mutation Analysis | MTHFR | Blood with EDTA | 15 DAYS |
MTHFR A1298C Mutation Analysis | MTHFR | Blood with EDTA | 15 DAYS |
Hydatidiform Mole, Recurrent, 2 | KHDC3L | Blood with EDTA | 40 DAYS |
Hydatidiform Mole, Recurrent, 1 (Gestational Trophoblastic Disease) | NLRP7 | Blood with EDTA | 40 DAYS |
FSH Receptor Gene Polymorphism Analysis | FSHR | Blood with EDTA | 40 DAYS |
FSH Beta Common Mutation Analysis | FSHB | Blood with EDTA | 40 DAYS |
Thrombophilia, Susceptibility to, due to Factor V Leiden | F5 | Blood with EDTA | 15 DAYS |
Thrombophilia due to Activated Protein C Resistance | F5 | Blood with EDTA | 15 DAYS |
Thrombophilia due to Factor 2 Defect | F2 | Blood with EDTA | 15 DAYS |
Hydatidiform mole NLRP7 MLPA | NLRP7 | Blood with EDTA | 40 DAYS |
Disorder of Sex Development (46XX Male) | Panel 1: CYP21A | Blood with EDTA | 30 DAYS |
LİM15 | N/A | Testicular Sperm Extraction | 21 DAYS |
Semen Haploidy Panel | N/A | Seminal Fluid | 20 DAYS |
Sperm DNA Damage Test Panel | N/A | Seminal Fluid | 10 DAYS |
Post Mayotic Sperm Panel | N/A | Seminal Fluid | 15 DAYS |
Activated NK Test | N/A | Special Activation Tube | 20 DAYS |
Flow Cytometric KIR Analysis | N/A | Heparinized Blood | 20 DAYS |
N - KIR Diagnosis/Follow Up Panel (Flow Cytometric KIR, Activated NK) | N/A | Heparinized Blood | 20 DAYS |
Sperm DNA Damage Test Tunel Flow | N/A | Seminal Fluid | 10 DAYS |
Sperm FISH Test (TESE Tissue) | N/A | Testicular Sperm Extraction | 15 DAYS |
Semen Apoptosis Detection (Annexin) | N/A | Seminal Fluid | 2 DAYS |
Semen Oxidative Stress Detection (ROS Analysis) | N/A | Seminal Fluid | 2 DAYS |
Spermatogenesis Marker Detection | N/A | Seminal Fluid | 20 DAYS |
HOST (Vitality Test) | N/A | Seminal Fluid | 40 DAYS |
Spermiogram | N/A | Seminal Fluid | 2 DAYS |
Sperm FISH Test | N/A | Seminal Fluid | 15 DAYS |
Sperm DNA Damage Test | N/A | Seminal Fluid | 10 DAYS |
Y Chromosome Microdeletion Screening | AZF - | Blood with EDTA | 15 DAYS |
SRY Analysis | SRY | Blood with EDTA | 15 DAYS |
PLC Zeta Whole Gene Sequence Analysis | PLCZ1 | Blood with EDTA | 40 DAYS |
Testicular Sperm Extraction Haploidy Panel | N/A | Testicular Sperm Extraction | 20 DAYS |
Preimplantation Genetic Diagnosis for Single Gene Disorders and HLA Typing | N/A | Embryo Biopsy | 1-7 DAYS |
Preimplantation Genetic Diagnosis for HLA Typing | N/A | Embryo Biopsy | 1-7 DAYS |
Preimplantation Genetic Diagnosis for Single Gene Disorders | N/A | Embryo Biopsy | 1-7 DAYS |
Translocation FISH | N/A | Embryo Biopsy | 1-2 DAYS |
Aneuploidy FISH (8 Chromosomes) | N/A | Embryo Biopsy | 1-2 DAYS |
Translocation Screening in Embryos with Array CGH | N/A | Embryo Biopsy | 1-2 DAYS |
24 Chromosome Screening in Embryos with Array CGH | N/A | Embryo Biopsy | 7 DAYS |
Translocation Screening in Embryos with NGS (Next Generation Sequencing) | N/A | Embryo Biopsy | 1-2 DAYS |
24 Chromosome Screening in Embryos with NGS (Next Generation Sequencing) | N/A | Embryo Biopsy | 7 DAYS |
Hypophosphatemic rickets, X-linked dominant | PHEX | Blood with EDTA | 40 DAYS |
Osteopetrosis, TNFSF11 (RANK LİGAND) | TNFSF11 (RANK LİGAND) | Blood with EDTA | 40 DAYS |
Osteopetrosis, TNFRSF11A (RANK) | TNFRSF11A (RANK) | Blood with EDTA | 40 DAYS |
Osteopetrosis, OSTM1 | OSTM1 | Blood with EDTA | 40 DAYS |
EhlerDanlos Syndrome Type 7A | COL1A1 | Blood with EDTA | 40 DAYS |
Robinow Syndrome (ROR2 MLPA) | ROR2 | Blood with EDTA | 40 DAYS |
Periodic Fever Panel (6 Gene) | ELAN | Blood with EDTA | 40 DAYS |
KRT17 Sequence Analysis | KRT17 | Blood with EDTA | 40 DAYS |
Cutis Laxa Type1A | FBLN5 | Blood with EDTA | 40 DAYS |
Spondylometaphyseal Displasia Kozlowski Type | TRPV4 | Blood with EDTA | 40 DAYS |
Tar Syndrome | RBM8A | Blood with EDTA | 40 DAYS |
NF2 MLPA Deletion/Duplication Analyses | NF2 | Blood with EDTA | 40 DAYS |
EEC Syndrome 1 | TP63 | Blood with EDTA | 40 DAYS |
Albinism Ocultaneous Type 1 | TYR | Blood with EDTA | 40 DAYS |
Neurofibromatosis Panel | NF | Blood with EDTA | 40 DAYS |
Ichthyosis with confetti | KRT10 | Blood with EDTA | 40 DAYS |
Fibrodysplasia Ossificans Progressiva | ACVR1 | Blood with EDTA | 40 DAYS |
Dyskeratosis Congenita ( X-linked ) | DKC1 | Blood with EDTA | 40 DAYS |
Ectodermal Dysplasia Syndactyly Syndrome 1 | NECTIN4 | Blood with EDTA | 40 DAYS |
Epiphyseal Dysplasia, Multiple, 7 | CANT1 | Blood with EDTA | 40 DAYS |
Neurofibromatosis, Type 1 MLPA Deletion/Duplication Analysis | NF1 | Blood with EDTA | 30 DAYS |
Spondyloepiphyseal Dysplasia Tarda | TRAPPC2 | Blood with EDTA | 40 DAYS |
Nail - Patella Syndrome | LMX1B | Blood with EDTA | 40 DAYS |
CINCA Syndrome | NLRP3 | Blood with EDTA | 40 DAYS |
Ichthyosis Histrix | KRT1 | Blood with EDTA | 40 DAYS |
Craniofrontonasal Dysplasia | EFNB1 | Blood with EDTA | 40 DAYS |
Familial Cold Autoinflammatory Syndrome 2 | NLRP12 | Blood with EDTA | 40 DAYS |
Ectodermal Dysplasia 10A | EDAR | Blood with EDTA | 40 DAYS |
Split Hand/Foot Malformation 6 | WNT10B | Blood with EDTA | 40 DAYS |
Osteogenesis Imperfecta, Type VII | CRTAP | Blood with EDTA | 40 DAYS |
Metaphyseal Chondrodysplasia, Schmid Type | COL10A1 | Blood with EDTA | 40 DAYS |
Ichthyosis, Congenital | TGM1 | Blood with EDTA | 40 DAYS |
Pseudoxanthoma Elasticum | ABCC6 | Blood with EDTA | 40 DAYS |
Klippel - Feil Syndrome 1 | GDF6 | Blood with EDTA | 40 DAYS |
Ehlers Danlos Syndrome, Musculocontractural Type 1 | CHST14 | Blood with EDTA | 40 DAYS |
SHOX Gene Deletion Analysis | SHOX | Heparinized Blood | 7 DAYS |
Steroid Sultfatase Deficiency/STS Gene Deletion Analysis | STS | Heparinized Blood | 7 DAYS |
Epidermolysis Bullosa Simplex Type 1 | KRT14 | Blood with EDTA | 40 DAYS |
Epidermolysis Bullosa Simplex Type 2 | KRT5 | Blood with EDTA | 40 DAYS |
Ichthyosis, Congenital, Autosomal Recessive 6 | NIPAL4 | Blood with EDTA | 40 DAYS |
ABCB6 Sequence Analysis | ABCB6 | Blood with EDTA | 40 DAYS |
Telangiectasia, Hereditary Hemorrhagic, Type 1 | ENG | Blood with EDTA | 40 DAYS |
Waardenburg Syndrome, Type 4A | EDNRB | Blood with EDTA | 40 DAYS |
Waardenburg Syndrome, Type 1/Type3 | PAX3 | Blood with EDTA | 40 DAYS |
Short Stature, Idiopathic Familial/Leri Weill Dyschondrosteosis | SHOX | Blood with EDTA | 40 DAYS |
Rickets, Vitamin D Dependent , Type I | CYP27B1 | Blood with EDTA | 40 DAYS |
Rickets, Vitamin D Resistant, Type IIA | VDR | Blood with EDTA | 40 DAYS |
Pfeiffer Syndrome | FGFR2 | Blood with EDTA | 40 DAYS |
Osteopetrosis, Autosomal Recessive 1 (Albers - Schonberg Disease) | TCIRG1 | Blood with EDTA | 40 DAYS |
Osteopetrosis, Autosomal Dominant 2/Osteopetrosis, Autosomal Recessive 4 | CLCN7 | Blood with EDTA | 40 DAYS |
Osteogenesis Imperfecta, Type II | COL1A2 | Blood with EDTA | 40 DAYS |
Osteogenesis Imperfecta, Type I | COL1A1 | Blood with EDTA | 40 DAYS |
Odontoonychodermal Dysplasia | WNT10A | Blood with EDTA | 40 DAYS |
Neurofibromatosis, Type 2 | NF2 | Blood with EDTA | 40 DAYS |
Neurofibromatosis, Type 1 (Von Recklinghausen Disease) | NF1 | Blood with EDTA | 40 DAYS |
Netherton Syndrome | SPINK5 | Blood with EDTA | 40 DAYS |
Exostoses, Multiple, Type 1 | EXT1 | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IIIB (Sanfilippo B) | NAGLU | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IVA (Morquio Syndrome) | GALNS | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome A) | SGSH | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type II (Hunter Syndrome) | IDS | Blood with EDTA | 40 DAYS |
Mucopolysaccharidosis Type 1H (Hurler Syndrome) | IDUA | Blood with EDTA | 40 DAYS |
Muckle - Wells Syndrome | NLRP3 | Blood with EDTA | 40 DAYS |
Loeys - Dietz Syndrome 2 (Marfan Syndrome Type 2) | TGFBR2 | Blood with EDTA | 40 DAYS |
Marfan Syndrome | FBN1 | Blood with EDTA | 40 DAYS |
Spondylocostal Dysostosis 1 (Jarcho - Levin Syndrome) | DLL3 | Blood with EDTA | 40 DAYS |
Ichthyosis, Congenital | ALOXE3 | Blood with EDTA | 40 DAYS |
Hypochondroplasia | FGFR3 | Blood with EDTA | 21 DAYS |
Ectodermal Dysplasia 1, Hypohidrotic, X - Linked (Christ Siemens Tourine Syndrome) | EDA | Blood with EDTA | 40 DAYS |
Hypophosphatasia | ALPL | Blood with EDTA | 40 DAYS |
Basal Cell Nevus Syndrome (Gorlin Syndrome) | PTCH1 | Blood with EDTA | 40 DAYS |
Focal Dermal Hypoplasia (Goltz Syndrome) | PORCN | Blood with EDTA | 40 DAYS |
FGFR3 Whole Gene Analysis | FGFR3 | Blood with EDTA | 40 DAYS |
Ehlers Danlos Syndrome, Arthrochalasia Type, 2 | COL1A2 | Blood with EDTA | 40 DAYS |
Ehlers Danlos Syndrome, Kyphoscoliotic Type, 1 | PLOD1 | Blood with EDTA | 40 DAYS |
Ehlers Danlos Syndrome, Vascular Type | COL3A1 | Blood with EDTA | 40 DAYS |
Ehlers Danlos Syndrome, Classic Like, 1 | TNXB | Blood with EDTA | 40 DAYS |
Ehlers Danlos Syndrome, Classic Type, 1 | COL5A1 | Blood with EDTA | 40 DAYS |
Crouzon Syndrome with Acanthosis Nigricans | FGFR3 | Blood with EDTA | 40 DAYS |
Arthrogryposis Multiplex Congenita Type 1 | TPM2 | Blood with EDTA | 40 DAYS |
Arthrogryposis, Renal Dysfunction and Cholestasis 2 Syndrome | VIPAS39 | Blood with EDTA | 40 DAYS |
Arthrogryposis, Renal Dysfunction and Cholestasis 1 Syndrome | VPS33B | Blood with EDTA | 40 DAYS |
Apert Syndrome | FGFR2 | Blood with EDTA | 40 DAYS |
Achondroplasia | FGFR3 | Blood with EDTA | 21 DAYS |
Ichthyosis, Congenital, Autosomal Recessive 2 | ALOX12B | Blood with EDTA | 40 DAYS |
Hypophosphatemic rickets, X-linked dominant | PHEX | Blood with EDTA | 40 DAYS |
Growth Hormone Deficiency Panel (3 Gene) | POU1F | Blood with EDTA | 40 DAYS |
Nephrotic Syndrome, Congenital (Fin Type) | NPHS1 | Blood with EDTA | 40 DAYS |
Bardet - Biedl Syndrome Type 17 | LZTFL1 | Blood with EDTA | 40 DAYS |
Pseudohypoaldosteronism Type 1 | SCNN1B | Blood with EDTA | 40 DAYS |
Pseudohypoaldosteronism Type 1 | SCNN1G | Blood with EDTA | 40 DAYS |
Thyroid Hormone Resistance/Refetoff Syndrome THRB Gene | THRB | Blood with EDTA | 40 DAYS |
Multiple Endocrine Neoplasia Type 1 | MEN1 | Blood with EDTA | 40 DAYS |
Hemacromatosis Panel | HF | Blood with EDTA | 40 DAYS |
LHCGR GENE POLYMORPHISM SCREENING | LHCGR | Blood with EDTA | 40 DAYS |
17 - Beta Hydroxysteroid Dehydrogenase 3 Deficiency | HSD17B3 | Blood with EDTA | 40 DAYS |
Obesity, Morbid, Type 2 | LEPR | Blood with EDTA | 40 DAYS |
Obesity, Morbid | LEP | Blood with EDTA | 30 DAYS |
Laron Dwarfism | GHR | Blood with EDTA | 30 DAYS |
Autoimmune Polyendocrinopathy Syndrome , Type I | AIRE | Blood with EDTA | 40 DAYS |
Bilateral Macronodular Adrenal Hyperplasia | ARMC5 | Blood with EDTA | 40 DAYS |
Antley - Bixler Syndrome | POR | Blood with EDTA | 40 DAYS |
Monocarboxylate Transporter 1 Deficiency | SLC16A1 | Blood with EDTA | 40 DAYS |
Pseudohypoaldosteronism, Type I | SCNN1A | Blood with EDTA | 40 DAYS |
Aromatase Deficiency | CYP19A1 | Blood with EDTA | 40 DAYS |
Hemolytic Uremic Syndrome, Atypical, Susceptibility to, 2 | CD46 | Blood with EDTA | 40 DAYS |
Neonatal Diabetes | YIPF5 | Blood with EDTA | 40 DAYS |
Donohue Syndrome | INSR | Blood with EDTA | 40 DAYS |
Pituitary Adenoma | AIP | Blood with EDTA | 40 DAYS |
Hyperinsulinism - Hyperammonemia Syndrome | GLUD1 | Blood with EDTA | 40 DAYS |
Pancreatitis, Hereditary | PRSS2 | Blood with EDTA | 40 DAYS |
Pancreatitis, Chronic | CTRC | Blood with EDTA | 40 DAYS |
Persistent Mullerian Duct Syndrome | AMH | Blood with EDTA | 40 DAYS |
Thrombotic Thrombocytopenic Purpura | ADAMTS13 | Blood with EDTA | 40 DAYS |
TSH Receptor (TSHR) Gene Polymorphism Analysis | TSHR | Blood with EDTA | 40 DAYS |
Obesity, Adrenal Insufficiency | POMC | Blood with EDTA | 40 DAYS |
Nephrotic Syndrome, Type 2 | NPHS2 | Blood with EDTA | 40 DAYS |
17 - Alpha Hydroxylase/17,20 - Lyase Deficiency | CYP17A1 | Blood with EDTA | 40 DAYS |
Hyperinsulinemic Hypoglycemia, Familial, 2 | KCNJ11 | Blood with EDTA | 40 DAYS |
Pituitary Hormone Deficiency, Combined, 1 | POU1F1 | Blood with EDTA | 40 DAYS |
Aldosterone Synthase Deficiency | CYP11B2 | Blood with EDTA | 40 DAYS |
Kallmann Syndrome (KAL1 gene Deletion Del Xp22.3) | KAL1 | Heparinized Blood | 7 DAYS |
Adrenal Hyperplasia, Congenital, due to 3 - Beta Hydroxysteroid Dehydrogenase 2 Deficiency | HSD3B2 | Blood with EDTA | 40 DAYS |
Hereditary Hypophosphatemic Rickets | FGF23 | Blood with EDTA | 40 DAYS |
Polycystic Kidney Disease (AD) Panel | PKD | Blood with EDTA | 40 DAYS |
Campomelic Dysplasia | SOX9 | Blood with EDTA | 40 DAYS |
Russel - Silver Syndrome | 11P15 | Blood with EDTA | 30 DAYS |
Renal Glucosuria | SLC5A2 | Blood with EDTA | 40 DAYS |
Cholestasis, Progressive Familial Intrahepatic 3 | ABCB4 | Blood with EDTA | 40 DAYS |
Cholestasis, Progressive Familial Intrahepatic 2 | ABCB11 | Blood with EDTA | 40 DAYS |
Cholestasis, Progressive Familial Intrahepatic 1 (PFIC) (Byler Disease) | ATP8B1 | Blood with EDTA | 40 DAYS |
Polycystic Kidney and Hepatic Disease | PKHD1 | Blood with EDTA | 40 DAYS |
Polycystic Kidney Disease, Adult Type I | PKD1 | Blood with EDTA | 40 DAYS |
Polycystic Kidney Disease 2, Adult | PKD2 | Blood with EDTA | 40 DAYS |
MODY, Type XI (Maturity - Onset Diabetes of the Young, Type 11) | BLK | Blood with EDTA | 40 DAYS |
MODY, Type X (Maturity - Onset Diabetes of the Young, Type 10) | INS | Blood with EDTA | 40 DAYS |
MODY, Type IX (Maturity - Onset Diabetes of the Young, Type 9) | PAX4 | Blood with EDTA | 40 DAYS |
MODY, Type VIII (Maturity - Onset Diabetes of the Young, Type 8) (Diabetes-Pancreatic Exocrine Dysfunction Syndrome) | CEL | Blood with EDTA | 40 DAYS |
MODY, Type VII (Maturity - Onset Diabetes of the Young, Type 7) | KLF11 | Blood with EDTA | 40 DAYS |
MODY, Type VI (Maturity - Onset Diabetes of the Young, Type 6) | NEUROD1 | Blood with EDTA | 40 DAYS |
MODY, Type V (Maturity - Onset Diabetes of the Young, Type 5) (Renal Cysts and Diabetes Syndrome) | HNF1B | Blood with EDTA | 40 DAYS |
MODY, Type IV (Maturity - Onset Diabetes of the Young, Type 4) | PDX1 | Blood with EDTA | 40 DAYS |
MODY, Type III (Maturity - Onset Diabetes of the Young, Type 3) | HNF1A | Blood with EDTA | 40 DAYS |
MODY, Type II (Maturity - Onset Diabetes of the Young, Type 2) | GCK | Blood with EDTA | 40 DAYS |
MODY, Type I (Maturity - Onset Diabetes of the Young, Type 1) | HNF4A | Blood with EDTA | 40 DAYS |
MODY Panel 4 | ABCC | Blood with EDTA | 40 DAYS |
MODY Panel 3 | BL | Blood with EDTA | 40 DAYS |
MODY Panel 2 | HNF1 | Blood with EDTA | 40 DAYS |
MODY Panel 1 | HNF4 | Blood with EDTA | 40 DAYS |
Multiple Endocrine Neoplasia, Type IV | CDKN1B | Blood with EDTA | 40 DAYS |
McCune - Albright Syndrome, Somatic, Mosaic | GNAS | Blood with EDTA | 40 DAYS |
Liddle Syndrome | SCNN1B | Blood with EDTA | 40 DAYS |
Liddle Syndrome | SCNN1G | Blood with EDTA | 40 DAYS |
Adrenal Hyperplasia, Congenital, (11 - Beta - Hydroxylase Deficiency) | CYP11B1 | Blood with EDTA | 40 DAYS |
Adrenal Hyperplasia, Congenital, (21 - Hydroxylase Deficiency) MLPA | CYP21A2 | Blood with EDTA | 30 DAYS |
Adrenal Hyperplasia, Congenital, (21 - Hydroxylase Deficiency) | CYP21A2 | Blood with EDTA | 40 DAYS |
Adrenal Hyperplasia, Congenital, (17 - Alpha - Hydroxylase/17,20 - Lyase Deficiency) | CYP17A1 | Blood with EDTA | 40 DAYS |
Pancreatitis, Hereditary, Chronic | SPINK1 | Blood with EDTA | 40 DAYS |
Pancreatitis, Hereditary | PRSS1 | Blood with EDTA | 40 DAYS |
Hypothyroidism | IGSF1 | Blood with EDTA | 40 DAYS |
Hypophosphatasia | ALPL | Blood with EDTA | 40 DAYS |
Hyperinsulinemic Hypoglycemia, Familial, 1 | ABCC8 | Blood with EDTA | 40 DAYS |
Hemolytic Uremic Syndrome, Atypical, Susceptibility to, 1 | CFH | Blood with EDTA | 40 DAYS |
Gilbert Syndrome | UGT1A1 | Blood with EDTA | 40 DAYS |
Growth Hormone Deficiency, Type IA | GH1 | Blood with EDTA | 40 DAYS |
Crigler - Najjar Syndrome, Type II | UGT1A1 | Blood with EDTA | 40 DAYS |
Calcium Sensing Receptor Mutation | CASR | Blood with EDTA | 40 DAYS |
Bartter Syndrome Type 1 | SLC12A1 | Blood with EDTA | 40 DAYS |
Androgen Receptor Polymorphism | AR | Blood with EDTA | 40 DAYS |
Alagille Syndrome 2 | NOTCH2 | Blood with EDTA | 40 DAYS |
Alagille Syndrome 1 | JAG1 | Blood with EDTA | 40 DAYS |
Hypercalciuric Hypercalcemia, Familial | CASR | Blood with EDTA | 40 DAYS |
5-Alpha-Reductase Deficiency | SRD5A2 | Blood with EDTA | 40 DAYS |
Roberts Syndrome | ESCO2 | Blood with EDTA | 30 DAYS |
Wolf-Hirchhorn Syndorme - 4p16 Deletion WHSC1 | N/A | Heparinized Blood | 7 DAYS |
Williams Syndrome - 7q11.23 Deletion | N/A | Heparinized Blood / Bone Marrow | 7 DAYS |
Sotos Syndrome Del 5q35 (NSD 1 Deletion) | NSD1 | Heparinized Blood | 7 DAYS |
Hay Wells Syndrome | TP63 | Blood with EDTA | 40 DAYS |
Cri du Chat Syndrome | -1 | Heparinized Blood | 15 DAYS |
Charge Syndrome | CHD7 | Heparinized Blood | 40 DAYS |
Alport Syndrome COL4A5 | COL4A5 | Blood with EDTA | 40 DAYS |
Alport Syndrome COL4A4 | COL4A4 | Blood with EDTA | 40 DAYS |
Alport Syndrome COL4A3 | COL4A3 | Blood with EDTA | 40 DAYS |
Barth syndrome | TAZ | Blood with EDTA | 30 DAYS |
Trichorinophalangeal Syndrome Type 1 | TRPS1 | Blood with EDTA | 40 DAYS |
Sotos Syndrome | NSD1 | Blood with EDTA | 40 DAYS |
Robinow Syndrome (ROR2 MLPA) | ROR2 | Blood with EDTA | 40 DAYS |
Noonan Syndrome Panel | PTPN11 | Blood with EDTA | 40 DAYS |
Coffin Lowry Syndrome | RPS6KA3 | Blood with EDTA | 40 DAYS |
Bardet - Biedl Syndrome Type 17 | LZTFL1 | Blood with EDTA | 40 DAYS |
Tar Syndrome | RBM8A | Blood with EDTA | 40 DAYS |
Ochoa Syndrome | HPSE2 | Blood with EDTA | 40 DAYS |
NOG Whole Gene Sequence Analysis | NOG | Blood with EDTA | 40 DAYS |
Angelman Syndrome MLPA | 15q11-13 | Blood with EDTA | 40 DAYS |
Simpson - Golabi- Behmel Syndrome | GPC3 | Blood with EDTA | 40 DAYS |
3-M Syndrome CUL7 | CUL7 | Blood with EDTA | 40 DAYS |
Treacher Collins Syndrome Panel | TCOF1 | Blood with EDTA | 40 DAYS |
Birt - Hogg - Dube Syndrome | FLCN | Blood with EDTA | 40 DAYS |
Ellis - Van Creveld Syndrome | EVC | Blood with EDTA | 40 DAYS |
Deafness, Digenic GJB2/GJB6 | GJB6 | Blood with EDTA | 40 DAYS |
Hermansky - Pudlak Syndrome 1 | HPS1 | Blood with EDTA | 40 DAYS |
Townes - Brocks Syndrome 1 | SALL1 | Blood with EDTA | 30 DAYS |
Opitz GBBB Syndrome, Type II | SPECC1L | Blood with EDTA | 30 DAYS |
Opitz GBBB Syndrome, Type I | MID1 | Blood with EDTA | 30 DAYS |
Branchiooculofacial Syndrome | TFAP2A | Blood with EDTA | 40 DAYS |
Kaufman Oculocerebrofacial Syndrome | UBE3B | Blood with EDTA | 40 DAYS |
Griscelli Syndrome, Type 2 | RAB27 | Blood with EDTA | 40 DAYS |
Treacher Collins Syndrome 3 | POLR1C | Blood with EDTA | 40 DAYS |
Treacher Collins Syndrome 2 | POLR1D | Blood With EDTA | 40 DAYS |
Axenfeld - Rieger Syndrome, Type 3 | FOXC1 | Blood with EDTA | 40 DAYS |
Tooth Agenesis | PAX9 | Blood with EDTA | 40 DAYS |
Craniofrontonasal Dysplasia | EFNB1 | Blood with EDTA | 40 DAYS |
Pendred Syndrome | SLC26A4 | Blood with EDTA | 40 DAYS |
Polydactyly, Postaxial, Types A1 and B | GLI3 | Blood with EDTA | 40 DAYS |
Axenfeld - Rieger Syndrome | PITX2 | Blood with EDTA | 40 DAYS |
Beckwith - Wiedemann Syndrome | CDKN1C | Blood with EDTA | 40 DAYS |
Mowat - Wilson Syndrome | ZEB2 | Blood with EDTA | 40 DAYS |
Ectodermal Dysplasia 10A | EDAR | Blood with EDTA | 40 DAYS |
Split Hand/Foot Malformation 6 | WNT10B | Blood with EDTA | 40 DAYS |
Robinow Syndrome | ROR2 | Blood with EDTA | 40 DAYS |
Berardinelli Syndrome | AGPAT2 | Blood with EDTA | 40 DAYS |
Klippel - Feil Syndrome 1 | GDF6 | Blood with EDTA | 40 DAYS |
PEHO Syndrome | ZNHIT3 | Blood with EDTA | 40 DAYS |
CODAS Syndrome | LONP1 | Blood with EDTA | 40 DAYS |
Auriculocondylar Syndrome 1 | GNAI3 | Blood with EDTA | 40 DAYS |
Coffin-Siris Syndrome 1 | ARID1B | Blood with EDTA | 40 DAYS |
Cornelia de Lange Syndrome 1 | NIPBL | Blood with EDTA | 41 DAYS |
Holt - Oram Syndrome | TBX5 | Blood with EDTA | 40 DAYS |
ABCB6 Sequence Analysis | ABCB6 | Blood with EDTA | 40 DAYS |
Telangiectasia, Hereditary Hemorrhagic, Type 1 | ENG | Blood with EDTA | 40 DAYS |
Floating - Harbor Syndrome | SRCAP | Blood with EDTA | 40 DAYS |
Carpenter Syndrome | RAB23 | Blood with EDTA | 40 DAYS |
Gorlin - Goltz Syndrome | SUFU | Blood with EDTA | 40 DAYS |
COL2A1 Sequence Analysis | COL2A1 | Blood with EDTA | 20 DAYS |
Peutz - Jeghers Syndrome STK11 MLPA | STK11 | Blood with EDTA | 21 DAYS |
Bardet Biedl Syndrome Panel | BBS1 | Blood with EDTA | 40 DAYS |
Acromesomelic Dysplasia, Maroteaux Type | NPR2 | Blood with EDTA | 40 DAYS |
PTEN Mutation Screening | PTEN | Blood with EDTA | 40 DAYS |
Fuhrmann Syndrome | WNT7A | Blood with EDTA | 40 DAYS |
Visceral Myopathy | ACTG2 | Blood with EDTA | 40 DAYS |
Multiple Endocrine Neoplasia IIA | RET | Blood with EDTA | 40 DAYS |
Weill - Marchesani Syndrome 1 (WMS) | ADAMTS10 | Blood with EDTA | 40 DAYS |
Waardenburg Syndrome, Type 4A | EDNRB | Blood with EDTA | 40 DAYS |
Waardenburg Syndrome, Type 1/Type3 | PAX3 | Blood with EDTA | 40 DAYS |
Treacher Collins Syndrome 1 | TCOF1 | Blood with EDTA | 40 DAYS |
Waardenburg Syndrome | SOX10 | Blood with EDTA | 40 DAYS |
Seckel Syndrome 1 (Bird - Headed Dwarfism ) | ATR | Blood with EDTA | 40 DAYS |
Rubinstein - Taybi Syndrome 1 (Broad Thumb - Hallux Syndrome) | CREBBP | Blood with EDTA | 40 DAYS |
Pseudoachondroplasia | COMP | Blood with EDTA | 40 DAYS |
Prader Willi/Angelman Syndrome MLPA | 15q11-13 | Blood with EDTA | 30 DAYS |
Noonan Syndrome Type 4 | SOS1 | Blood with EDTA | 40 DAYS |
Noonan Syndrome Type 1 | PTPN11 | Blood with EDTA | 40 DAYS |
Molecular Karyotyping (Whole Genome Deletion/Duplication Analysis) | N/A | Blood with EDTA | 30 DAYS |
Loeys - Dietz Syndrome Type 1 | TGFBR1 | Blood with EDTA | 40 DAYS |
Trichorhinophalangeal Syndrome, Type I (Langer Giedion Syndrome) | TRPS1 | Blood with EDTA | 40 DAYS |
Joubert Syndrome | NPHP3 | Blood with EDTA | 40 DAYS |
Joubert Syndrome 1 | INPP5E | Blood with EDTA | 40 DAYS |
Cockayne Syndrome, Type A | ERCC8 | Blood with EDTA | 40 DAYS |
Beckwith - Wiedemann Syndrome | 11p15 | Blood with EDTA | 30 DAYS |
Bardet Biedl Syndrome 2 | BBS2 | Blood with EDTA | 40 DAYS |
Bardet Biedl Syndrome 10 | BBS10 | Blood with EDTA | 40 DAYS |
Bardet Biedl Syndrome 1 | BBS1 | Blood with EDTA | 40 DAYS |
Prader Willi/Angelman Syndrome | SNRPN | Heparinized Blood / Bone Marrow | 30 DAYS |
Sibling Test | N/A | Blood with EDTA | 20 DAYS |
Maternity Test | N/A | Blood with EDTA | 20 DAYS |
Renal Osteodystrophy Panel | BGLA | Blood with EDTA | 30 DAYS |
Whole Exome Sequencing (WES) Gold Trio + Mitochondrial Screening | N/A | Blood with EDTA | 60 DAYS |
Whole Exome Sequencing (WES) Gold Solo + Mitochondrial Screening | N/A | Blood with EDTA | 60 DAYS |
Inherited Diseases Panel | 570 Gene | Blood with EDTA | 40 DAYS |
DNA Isolation (Storage) | -1 | -1 | X |
DiGeorge Syndrome | -1 | -1 | 7 DAYS |
Inherited Diseases Panel | 164 Gene | -1 | -1 |
Atypical Hemolytic-Uremic Syndrome | Panel 1: CFH2
Panel 2: CF | Blood with EDTA | 30 DAYS |
Central Hypoventilation Syndrome | PHOX2B | Blood with EDTA | 30 DAYS |
Periodic Fever Panel (6 Gene) | ELAN | Blood with EDTA | 40 DAYS |
Nephrotic Syndrome, Congenital (Fin Type) | NPHS1 | Blood with EDTA | 40 DAYS |
Prenatal Known Mutation | N/A | Blood with EDTA | 40 DAYS |
KCNJ2 Sequence Analysis | KCNJ2 | Blood with EDTA | 40 DAYS |
Prenatal Known Mutation 1 - 3 | N/A | Blood with EDTA | 40 DAYS |
Non-Syndrome Hearing Loss (GJB6) | GJB6 | Blood with EDTA | 40 DAYS |
Congenital Deafness (GJB2 Whole Gene Analysis) | GJB2 | Blood with EDTA | 40 DAYS |
Hemolytic Uremic Syndrome - AHUS3 - CFI Factor-I | AHUS3 - CFI | Blood with EDTA | 40 DAYS |
? | N/A | Blood with EDTA | 40 DAYS |
DNA Isolation (Storage) | N/A | Blood with EDTA | 40 DAYS |
FMF (Familial Mediterranean Fever) (Exon 1, 4, 6, 7, 8, 9) | MEFV | Blood with EDTA | 40 DAYS |
Congenital Deafness (Convergine 26 Whole Gene) | GJB2 | Blood with EDTA | 40 DAYS |
FMF (Familial Mediterranean Fever) (Exon 2, 3, 5, 10) | MEFV | Blood with EDTA | 40 DAYS |
Alpha-1 Antitrypsin Deficiency Common Mutation | SERPINA1 | Blood with EDTA | 40 DAYS |
CX3CR1 Dizi Analizi | CX3CR1 | Blood with EDTA | 40 DAYS |
Van Der Knaap Disease MLC3 Type MYL1 | MYL1 (MLC2) | Blood with EDTA | 40 DAYS |
Van Der Knaap Disease MLC2 Type MYL9 | MYL9 (MLC2) | Blood with EDTA | 40 DAYS |
Clinical Exome Sequencing (4813 Genes) | 4813 Genes | Blood with EDTA | 40 DAYS |
Polycystic Kidney Disease Panel | PKD | Blood with EDTA | 40 DAYS |
Hypercholanemia, Familial | TJP2 | Blood with EDTA | 30 DAYS |
Whole Exome Sequencing Platinium Solo | N/A | Blood with EDTA | 90 DAYS |
SLC15A3 Gene Screening | SLC15A3 | Blood with EDTA | 30 DAYS |
Cardiomyopathy, Hypertrophic, 7 | TNNI3 | Blood with EDTA | 40 DAYS |
Hemolytic Uremic Syndrome, Atypical, Susceptibility to, 2 | CD46 | Blood with EDTA | 40 DAYS |
Deafness, Digenic, GJB2/GJB3 | GJB3 | Blood with EDTA | 40 DAYS |
Nephronophthisis 1 | NPHP1 | Blood with EDTA | 40 DAYS |
Nephrotic Syndrome, Type 2 | NPHS2 | Blood with EDTA | 40 DAYS |
Branchiootic Syndrome 1 | EYA1 | Blood with EDTA | 40 DAYS |
Inherited Disease Panel (297 Genes) | 297 Genes | Blood with EDTA | 40 DAYS |
Subtelomeric FISH/Subtelomeric Deletion Screening | N/A | Heparinized Blood | 15 DAYS |
Chromosome Analysis from Skin Biopsy Material | N/A | Skin Biopsy | 28 DAYS |
Chromosome Analysis from Peripheral Blood | N/A | Heparinized Blood | 21 DAYS |
Polycystic Kidney Disease (AD) Panel | PKD | Blood with EDTA | 40 DAYS |
Whole Genome Sequencing (WES) Trio | N/A | Blood with EDTA | 60 DAYS |
Whole Genome Sequencing (WES) Solo | N/A | Blood with EDTA | 60 DAYS |
Whole Exome Sequencing (WES) Trio | N/A | Blood with EDTA | 60 DAYS |
Whole Exome Sequencing (WES) Solo | N/A | Blood with EDTA | 60 DAYS |
Renal Tubular Acidosis with Deafness | ATP6V1B1 | Blood with EDTA | 40 DAYS |
Renal Tubular Acidosis, Distal, Autosomal Recessive | ATP6V0A4 | Blood with EDTA | 40 DAYS |
Osteopetrosis, Autosomal Recessive 3, with Renal Tubular Acidosis | CA2 | Blood with EDTA | 40 DAYS |
Renal Glucosuria | SLC5A2 | Blood with EDTA | 40 DAYS |
Chromosome Analysis with QF - PCR | 20 Marker | Chorionic Villus | 5 DAYS |
Cholestasis, Progressive Familial Intrahepatic 3 | ABCB4 | Blood with EDTA | 40 DAYS |
Cholestasis, Progressive Familial Intrahepatic 2 | ABCB11 | Blood with EDTA | 40 DAYS |
Cholestasis, Progressive Familial Intrahepatic 1 (PFIC) (Byler Disease) | ATP8B1 | Blood with EDTA | 40 DAYS |
Polycystic Kidney and Hepatic Disease | PKHD1 | Blood with EDTA | 40 DAYS |
Polycystic Kidney Disease, Adult Type I | PKD1 | Blood with EDTA | 40 DAYS |
Polycystic Kidney Disease 2, Adult | PKD2 | Blood with EDTA | 40 DAYS |
Congenital Deafness | GJB2 | Blood with EDTA | 40 DAYS |
Cystic Fibrosis MLPA | CFTR | Blood with EDTA | 30 DAYS |
Cystic Fibrosis Whole Gene Analysis | CFTR | Blood with EDTA | 40 DAYS |
Cardiovascular Risk Panel (6 Mutation) | N/A | Blood with EDTA | 21 DAYS |
Cardiovascular Risk Panel (12 Mutation) | N/A | Blood with EDTA | 21 DAYS |
Ciliary Dyskinesia, Primary, 7 | DNAH11 | Blood with EDTA | 40 DAYS |
Ciliary Dyskinesia, Primary, 3 | DNAH5 | Blood with EDTA | 40 DAYS |
Gilbert Syndrome | UGT1A1 | Blood with EDTA | 40 DAYS |
Familial Mediterranean Fever | MEFV | Blood with EDTA | 30 DAYS |
DNA Fingerprinting | N/A | Blood with EDTA | 21 DAYS |
Diarrhea 1, Secretory Chloride, Congenital | SLC26A3 | Blood with EDTA | 40 DAYS |
Central Hypoventilation Syndrome, Congenital | ASCL1 | Blood with EDTA | 40 DAYS |
Alpha-1 Antitrypsin Deficiency | SERPINA1 | Blood with EDTA | 40 DAYS |
Paternity Test | N/A | Blood with EDTA / Mucosa / Amniotic Fluid | 20 DAYS |
Whole Exome Sequencing (WES), Additional Family Member | N/A | Blood with EDTA | 60 DAYS |
? | N/A | Blood with EDTA | 40 DAYS |